N

Nurix Therapeutics

Drug discovery targeting ubiquitin E3 ligases

Senior Director, Manufacturing Operations

Supply Chain ManagementPosted on Nov 14
Full-timeBrisbane, CA, USA$270.3k - $295.7k

About the Job

Requirements

  • A Bachelor of Science degree and 15 or more years of experience in Pharmaceutical Chemistry, Organic Chemistry, Pharmaceutics, Pharmaceutical Science, or a related scientific discipline.
  • At least 10 years of relevant experience in a pharmaceutical or biotechnology CMC/cGMP environment.
  • Strong project management skills and the ability to work cross-functionally to develop and execute project plans.
  • Experience managing U.S. and international Contract Research Organizations and Contract Manufacturing Organizations for the manufacture of raw materials, registered starting materials, and cGMP drug substance and drug product for programs in development.
  • Experience with clinical supply chain management, including forecasting supply needs.
  • Experience with cGMP manufacturing and IND, CTA, and NDA filings, and thorough knowledge of relevant FDA and EMEA regulations.
  • Experience in supply chain management, including establishing pharmaceutical supply chain systems and networks.
  • Ability to identify and resolve critical issues.
  • Sufficient technical background and experience to work closely with other technical functional areas.
  • Strong written and verbal communication skills and interpersonal and management skills to collaborate with internal teams and external collaborators on assigned projects.

Responsibilities

  • Identify, select, and manage Contract Manufacturing Organizations for the development and cGMP manufacture of raw materials, registered starting materials, and drug substance supporting clinical programs and commercial products, in coordination with finance and commercial teams.
  • Manage global supply chains and logistics to meet demand for clinical studies and commercial products.
  • Provide vendor management support in logistics and operations, working with technical teams to ensure on-time delivery of materials.
  • Coordinate the design and execution of cross-functional CMC project plans and budgets from early clinical development through commercial readiness.
  • Maintain communication with cross-functional CMC project members and internal stakeholders about project status, issues, contingencies, milestones, and budgets.
  • Identify CMC critical paths, risks, and impediments to development, and drive solutions to mitigate them.
  • Serve as the primary clinical supply chain contact, collaborating with internal and external partners.
  • Manage clinical supply planning and forecasting for study protocols, and develop packaging, labeling, and global distribution strategies.
  • Monitor IXRS portal processes, including high- and low-enrolling site settings, drug acknowledgment, depot and site supply levels, and released-lot or expired-drug status.
  • Coordinate preparation and/or review of CMC sections of INDs, CTAs, NDAs, MAAs, and other regulatory submissions to ensure timely distribution of clinical trial materials.
  • Coordinate process validation programs to support commercialization.
  • Initiate and manage high-value intercontinental, cross-border, and domestic shipments.
  • Coordinate preparation, review, editing, and approval of cGMP batch records and CMC regulatory and Quality documents.
  • Coordinate preparation of technical reports, publications, and oral presentations.

Desired Qualifications

  • An advanced degree in Pharmaceutical Chemistry, Organic Chemistry, Pharmaceutics, Pharmaceutical Science, or a related scientific discipline.
  • Experience managing U.S. and international Contract Manufacturing Organizations for commercial programs.

About the Company

Nurix Therapeutics

Drug discovery targeting ubiquitin E3 ligases

Nurix Therapeutics develops drugs that use the body's own protein-degradation system to treat diseases. Its core approach is to control ubiquitin E3 ligases, enzymes that tag unwanted proteins for breakdown in cells. By modulating these ligases, Nurix aims to create therapeutics, especially small-molecule immuno-oncology agents, that can selectively remove disease-related proteins in cancer and other serious conditions. The company operates by discovering and developing drug candidates and earning revenue through partnerships, licensing, and potential future sales of its medicines. Unlike many biotech firms that target single proteins, Nurix focuses on the protein-degradation pathway to influence multiple disease processes through carefully designed molecules. The goal is to bring new cancer treatments and other therapies to patients by advancing its degrader-based drugs through research, collaboration, and development toward commercial use.

Company size
201-500
Company stage
IPO
Headquarters
Brisbane, CA
Founded
2012

Recently Posted Jobs

Explore more opportunities at Nurix Therapeutics

See more jobs